相似文献
1
Treatment of hepatitis C 2010: a focus on protease inhibitors.
S D Med. 2010 Jun;63(6):214-5.
2
Excitement grows for potential revolution in hepatitis C virus treatment.
Nat Rev Drug Discov. 2010 Jul;9(7):501-3. doi: 10.1038/nrd3214.
3
Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012.
Emerg Infect Dis. 2015 Jan;21(1):186-8. doi: 10.3201/eid2101.141025.
4
Worth the wait. New, more effective therapies for hepatitis C are on the way.
Posit Aware. 2011 Jan-Feb;23(1):15-8.
5
Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
Gastroenterology. 2007 Jun;132(7):2283-4. doi: 10.1053/j.gastro.2007.04.063.
6
New hepatitis C regimen stimulates changes in therapy management.
Manag Care. 2011 Dec;20(12):41-2.
7
[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
MMW Fortschr Med. 2011 Jul 21;153(29-31):17.
8
Protease inhibitors in hepatitis C: from chronic disease to cure.
Ir Med J. 2011 Sep;104(8):230-1.
9
Hepatitis C virus therapies.
Nat Rev Drug Discov. 2006 Sep;5(9):715-6. doi: 10.1038/nrd2134.
10
PROVE data released on telaprevir.
AIDS Patient Care STDS. 2007 May;21(5):369. doi: 10.1089/apc.2007.9979.
Zotero 插件